Background: The aim of this study was to determine the incidence, outcomes, and risk factors for synechia formation after endoscopic sinus surgery (ESS) and middle turbinate medialization with and without FloSeal.

Methods: A retrospective review was performed of patients who underwent primary ESS with middle turbinate medialization, with or without the placement of FloSeal. Medialization was performed with the placement of an absorbable conchopexy suture and silastic splint. Operative variables and outcomes were analyzed to identify risk factors for synechia formation.

Results: One hundred thirty-five patients underwent medialization alone and 37 patients underwent medialization with placement of FloSeal. Overall, synechia formation was noted in 16 patients (9.3%). A statistically significant higher incidence of synechia formation was noted in patients who underwent middle turbinate medialization with the placement of FloSeal versus medialization alone (18.9% versus 6.7%). The incidences of intraoperative complications (6.2% versus 4.7%) and postoperative complications (6.2% versus 7%) were similar between patients with and without synechia, respectively. Patients experiencing synechia, however, underwent a statistically significant higher rate of revision procedures (25% versus 5.1%).

Conclusion: Despite adequate prevention with middle turbinate medialization, synechia formation after ESS may result in higher rates of revision procedures. The placement of FloSeal in conjunction with middle turbinate medialization may result in a higher incidence of synechia formation.

Download full-text PDF

Source
http://dx.doi.org/10.2500/ajr.2007.21.2986DOI Listing

Publication Analysis

Top Keywords

synechia formation
24
middle turbinate
24
turbinate medialization
24
patients underwent
16
placement floseal
16
medialization placement
12
medialization
10
synechia
9
formation endoscopic
8
endoscopic sinus
8

Similar Publications

Objectives: This review aims to evaluate the utility of nonmedicated middle meatal packing compared to no packing on synechia formation up to 12 weeks after endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS).

Methods: We conducted a systematic review according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A literature search was performed on Medline (PubMed), EBSCO CINAHL plus, CENTRAL, and Clinicaltrials.

View Article and Find Full Text PDF

Introduction: Idiopathic congenital acorea is extremely rare. There are several techniques for preserving the clear lens during pupil formation.

Case Presentation: The complete pupil absence caused acute glaucoma attack 2 weeks after birth, which was controlled in a 1-month-old child by peripheral iridectomy and disconnecting iris-corneal synechias.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess how common intrauterine synechiae (scar tissue) are after women undergo medically-treated postpartum hemorrhage (PPH) and how different treatment methods might influence this condition.
  • Conducted at Angers University Hospital, the study involved 83 women who experienced PPH, with diagnostic hysteroscopy performed 12 weeks after delivery to check for synechiae.
  • Findings showed that 24% of participants had mild synechiae, with second manual uterine examinations and bimanual massage identified as key risk factors, indicating a need for more research on the long-term effects of these complications.
View Article and Find Full Text PDF
Article Synopsis
  • Adhesion of the middle turbinate to the nasal cavity and synechia in the middle meatus are common causes for failed surgeries in chronic sinusitis patients.
  • The study introduces a new intranasal splint, designed with 3D modeling and made of biocompatible material, to prevent these complications post-surgery.
  • Initial testing with 20 volunteers showed the splint is safe, comfortable, and effective in preventing synechiae, but further research with a larger group is needed to confirm its clinical effectiveness.
View Article and Find Full Text PDF

Anterior Uveitis After Discontinuation of Janus Kinase Inhibitor, Ruxolitinib.

J Med Cases

August 2024

Department of Pathology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama City 700-8558, Japan.

Primary myelofibrosis shows widespread fibrosis in the bone marrow and is part of myeloproliferative neoplasms in which gene mutations in hematopoietic stem cells lead to abnormal clonal expansion of one or more lineage of myeloid and erythroid cells and megakaryocytes. Janus kinase (JAK) inhibitors are the main therapeutic regimen for primary myelofibrosis which harbors gene mutations, resulting in continuous activation of JAK-STAT signaling pathway. Since JAK inhibitors modulate immunological state, the administration would have a potential for uveitis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!